Clinical Characteristics and Short-Term Outcomes of HIV Patients Admitted to an African Intensive Care Unit

Table 4

Univariate analysis of key characteristics by survival outcome.

Variable	Categories	Combined	Survived	Died
Sex	Male	47 (46.53)	19 (43.18)	28 (49.12)	0.55
	Female	54 (53.47)	25 (56.82)	29 (50.88)
CD4 range	Above 300	12 (11.88)	7 (15.91)	5 (8.77)	0.02
	100 to 300	30 (29.70)	18 (40.91)	12 (21.05)
	Below 100	57 (58.42)	19 (43.18)	40 (70.18)
HAART	On HAART	56 (55.45)	23 (52.27)	33 (57.89)	0.57
	HAART naive	45 (44.55)	21 (47.73)	24 (42.11)
ARV regimen	1st line	37 (36.63)	14 (31.82)	23 (40.35)	0.49
	2nd line	12 (11.88)	7 (15.91)	5 (8.77)
	Not known	7 (6.93)	2 (4.55)	5 (8.77)
	Naive	45 (44.55)	21 (47.73)	24 (42.11)
Cotrimoxazole	Yes	69 (68.32)	30 (68.18)	39 (68.42)	0.98
	No	32 (31.68)	14 (31.82)	18 (31.58)
Abnormal electrolytes	Yes	11 (10.89)	6 (13.64)	5 (8.77)	0.52
	No	90 (89.11)	38 (86.36)	52 (91.23)
Time on HAART	Not known	62 (61.39)	29 (65.91)	33 (57.89)	0.42
	Less than 1 month	15 (14.85)	7 (15.91)	8 (14.04)
	1 to 6 months	7 (6.93)	1 (2.27)	6 (10.53)
	Beyond 6 months	17 (16.83)	7 (15.91)	10 (17.54)
Septic shock	Yes	37 (36.63)	7 (15.91)	30 (52.63)	0.00
	No	64 (63.37)	37 (84.09)	27 (47.37)
Ventilator	Yes	57 (56.44)	12 (27.27)	45 (78.95)	0.00
	No	44 (43.56)	32 (72.73)	12 (21.05)
Urea	Low (<8 mg/dL)	1 (1.35)	1 (2.78)	0 (0)	0.58
	Normal	19 (25.68)	9 (25.00)	10 (26.32)
	High (>20 mg/dL)	54 (72.97)	26 (72.22)	28 (73.68)
Creatinine	Low (<50 μmol/L)	36 (48.00)	20 (54.05)	16 (42.11)	0.41
	Normal	3 (4.00)	2 (5.41)	1 (2.63)
	High (>150 μmol/L)	36 (48.00)	15 (40.54)	21 (55.26)
Albumin	Low (<30 mg/dL)	44 (83.02)	20 (76.92)	24 (88.83)	0.29
	Normal	9 (16.98)	6 (23.08)	3 (11.11)
Hemoglobin	Normal	13 (15.85)	7 (17.50)	6 (14.29)	0.85
	Mild anemia	22 (26.83)	10 (25.00)	12 (28.57)
	Moderate anemia	23 (28.05)	10 (25.00)	13 (30.95)
	Severe anemia	24 (29.27)	13 (32.50)	11 (26.19)